Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophages

British Journal of Pharmacology

Volumn 142, Issue 5, 2004, Pages 890-898

  Yona, Simon ^a   Buckingham, Julia C ^b   Perretti, Mauro ^a   Flower, Roderick J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

CD11b; Inflammation; Zymosan

Indexed keywords

CD11B ANTIGEN; CYCLOOXYGENASE 2; DECTIN 1; LIPOCORTIN 1; PROSTAGLANDIN E2; PROTEIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CROSS LINKING; ELECTRON MICROSCOPY; HEATING; INCUBATION TIME; INTERMETHOD COMPARISON; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NULL ALLELE; OPSONIZATION; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PHENOMENOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SOLUBILITY; STIMULUS RESPONSE; WILD TYPE;

ANIMALS; ANNEXIN A1; CELL MEMBRANE; DINOPROSTONE; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, KNOCKOUT; PHAGOCYTOSIS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; ZYMOSAN;

EID: 3242890010     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705858     Document Type: Article

References (54)

1. ADEREM, A. & UNDERHILL, D.M. (1999). Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol., 17, 593-623.
2. AMBROSE, M.P., BAHNS, C.L. & HUNNINGHAKE, G.W. (1992). Lipocortin I production by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol., 6, 17-21.
3. ARUR, S., UCHE, U.E., REZAUL, K., FONG, M., SCRANTON, V., COWAN, A.E., MOHLER, W. & HAN, D.K. (2003). Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell, 4, 587-598.
4. AVNI, O., PUR, Z., YEFENOF, E. & BANIYASH, M. (1998). Complement receptor 3 of macrophages is associated with galectin-1-like protein. J. Immunol., 160, 6151-6158.
5. BECKER, J. & GRASSO, R.J. (1988). Suppression of yeast ingestion by dexamethasone in macrophage cultures: evidence for a steroid-induced phagocytosis inhibitory protein. Int. J. Immunopharmacol., 10, 325-338.
6. BECKER, J.L., GRASSO, R.J. & DAVIS, J.S. (1988). Dexamethasone action inhibits the release of arachidonic acid from phosphatidylcholine during the suppression of yeast phagocytosis in macrophage cultures. Biochem. Biophys. Res. Commun., 153, 583-590.
7. BROWN, E.J. (1991). Complement receptors and phagocytosis. Curr. Opin. Immunol., 3, 76-82.
8. BROWN, G.D. & GORDON, S. (2001). Immune recognition. A new receptor for beta-glucans. Nature, 413, 36-37.
9. BROWN, G.D., HERRE, J., WILLIAMS, D.L., WILLMENT, J.A., MARSHALL, A.S. & GORDON, S. (2003). Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med., 197, 1119-1124.
10. BROWN, G.D., TAYLOR, P.R., REID, D.M., WILLMENT, J.A., WILLIAMS, D.L., MARTINEZ-POMARES, L., WONG, S.Y. & GORDON, S. (2002). Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med., 196, 407-412.
11. BUCKINGHAM, J.C. & FLOWER, R.J. (1997). Lipocortin 1: a second messenger of glucocorticoid action in the hypothalamo-pituitary-adrenocortical axis. Mol. Med. Today, 3, 296-302.
12. BURTON, J.L., KEHRLI JR, M.E., KAPIL, S. & HORST, R.L. (1995). Regulation of L-selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone. J. Leukoc. Biol., 57, 317-325.
13. COMERA, C. & RUSSO-MARIE, F. (1995). Glucocorticoid-induced annexin 1 secretion by monocytes and peritoneal leukocytes. Br. J. Pharmacol., 115, 1043-1047.
14. CROXTALL, J.D., GILROY, D.W., SOLITO, E., CHOUDHURY, Q., WARD, B.J., BUCKINGHAM, J.C. & FLOWER, R.J. (2003). Attenuation of glucocorticoid functions in an Anx-A1 -/- cell line. Biochem. J., 371, 927-935.
15. DAS, A.M., FLOWER, R.J., HELLEWELL, P.G., TEIXEIRA, M.M. & PERRETTI, M. (1997). A novel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment. Br. J. Pharmacol., 121, 97-104.
16. DE CATERINA, R., SICARI, R., GIANNESSI, D., PAGGIARO, P.L., PAOLETTI, P., LAZZERINI, G., BERNINI, W., SOLITO, E. & PARENTE, L. (1993). Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J. Appl. Physiol., 75, 2368-2375.
17. DEWITT, S. & HALLETT, M.B. (2002). Cytosolic free Ca(2+) changes and calpain activation are required for beta integrin-accelerated phagocytosis by human neutrophils. J. Cell Biol., 159, 181-189.
18. DIAKONOVA, M., GERKE, V., ERNST, J., LIAUTARD, J.P., VAN DER VUSSE, G. & GRIFFITHS, G. (1997). Localization of five annexins in J774 macrophages and on isolated phagosomes. J. Cell Sci., 110, 1199-1213.
19. DREVETS, D.A. & CAMPBELL, P.A. (1991). Macrophage phagocytosis: use of fluorescence microscopy to distinguish between extracellular and intracellular bacteria. J. Immunol. Methods, 142, 31-38.
20. EUZGER, H.S., FLOWER, R.J., GOULDING, N.J. & PERRETTI, M. (1999). Differential modulation of annexin I binding sites on monocytes and neutrophils. Mediators Inflamm., 8, 53-62.
21. EZEKOWITZ, R.A., SIM, R.B., HILL, M. & GORDON, S. (1984). Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan. J. Exp. Med., 159, 244-260.
22. FERREIRA, S.H., CUNHA, F.Q., LORENZETTI, B.B., MICHELIN, M.A., PERRETTI, M., FLOWER, R.J. & POOLE, S. (1997). Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br. J. Pharmacol., 121, 883-888.
23. FILEP, J.G., DELALANDRE, A., PAYETTE, Y. & FOLDES-FILEP, E. (1997). Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils. Circulation, 96, 295-301.
24. FLOWER, R.J. (1988). Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br. J. Pharmacol., 94, 987-1015.
25. FLOWER, R.J. & ROTHWELL, N.J. (1994). Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol. Sci., 15, 71-76.
26. GAVINS, F.N., YONA, S., KAMAL, A.M., FLOWER, R.J. & PERRETTI, M. (2003). Leukocyte antiadhesive actions of annexin 1: ALXR-and FPR-related anti-inflammatory mechanisms. Blood, 101, 4140-4147.
27. GERKE, V. & MOSS, S.E. (2002). Annexins: from structure to function. Physiol. Rev., 82, 331-371.
28. GETTING, S.J., FLOWER, R.J. & PERRETTI, M. (1997). Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1. Br. J. Pharmacol., 120, 1075-1082.
29. GIAIMIS, J., LOMBARD, Y., POINDRON, P. & MULLER, C.D. (1994). Flow cytometry distinction between adherent and phagocytized yeast particles. Cytometry, 17, 173-178.
30. GORDON, S. (2003). Alternative activation of macrophages. Nat. Rev. Immunol., 3, 23-35.
31. GOULDING, N.J., EUZGER, H.S., BUTT, S.K. & PERRETTI, M. (1998). Novel pathways for glucocorticoid effects on neutrophils in chronic inflammation. Inflamm. Res., 47 (Suppl 3), S158-S165.
32. HANNON, R., CROXTALL, J.D., GETTING, S.J., ROVIEZZO, F., YONA, S., PAUL-CLARK, M.J., GAVINS, F.N., PERRETTI, M., MORRIS, J.F., BUCKINGHAM, J.C. & FLOWER, R.J. (2003). Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB. J., 17, 253-255.
33. HARRICANE, M.C., CARON, E., PORTE, F. & LIAUTARD, J.P. (1996). Distribution of annexin I during non-pathogen or pathogen phagocytosis by confocal imaging and immunogold electron microscopy. Cell Biol. Int., 20, 193-203.
34. HIRSCH, S. & GORDON, S. (1983). Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4. Immunogenetics, 18, 229-239.
35. KUSUMAWATI, A., LIAUTARD, J.P. & SRI WIDADA, J. (2001). Implication of annexin 1 in phagocytosis: effects of n-terminal domain deletions and point mutations of the phosphorylation site Ser-27. Cell Biol. Int., 25, 809-813.
36. LE CABEC, V., COLS, C. & MARIDONNEAU-PARINI, I. (2000). Nonopsonic phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation. Infect. Immun., 68, 4736-4745.
37. LIM, L.H., FLOWER, R.J., PERRETTI, M. & DAS, A.M. (2000). Glucocorticoid receptor activation reduces CD11b and CD49d levels on murine eosinophils: characterization and functional relevance. Am. J. Respir. Cell Mol. Biol., 22, 693-701.
38. LIM, L.H., SOLITO, E., RUSSO-MARIE, F., FLOWER, R.J. & PERRETTI, M. (1998). Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc. Natl. Acad. Sci. U.S.A., 95, 14535-14539.
39. MARIDONNEAU-PARINI, I., ERRASFA, M. & RUSSO-MARIE, F. (1989). Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages. J. Clin. Invest., 83, 1936-1940.
40. MINGHETTI, L., NICOLINI, A., POLAZZI, E., GRECO, A., PERRETTI, M., PARENTE, L. & LEVI, G. (1999). Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. Br. J. Pharmacol., 126, 1307-1314.
41. OLIANI, S.M., CHRISTIAN, H.C., MANSTON, J., FLOWER, R.J. & PERRETTI, M. (2000). An immunocytochemical and in situ hybridization analysis of annexin l expression in rat mast cells: modulation by inflammation and dexamethasone. Lab. Invest., 80, 1429-1438.
42. PEERS, S.H., SMILLIE, F., ELDERFIELD, A.J. & FLOWER, R.J. (1993). Glucocorticoid-and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo. Br. J. Pharmacol., 108, 66-72.
43. PERRETTI, M. (1998). Lipocortin 1 and chemokine modulation of granulocyte and monocyte accumulation in experimental inflammation. Gen. Pharmacol., 31, 545-552.
44. PERRETTI, M., CROXTALL, J.D., WHELLER, S.K., GOULDING, N.J., HANNON, R. & FLOWER, R.J. (1996). Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat. Med., 2, 1259-1262.
45. PERRETTI, M. & FLOWER, R.J. (1996). Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation. Br. J. Pharmacol., 118, 605-610.
46. ROSS, G.D., VETVICKA, V., YAN, J., XIA, Y. & VETVICKOVA, J. (1999). Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology, 42, 61-74.
47. ROVIEZZO, F., GETTING, S.J., PAUL-CLARK, M.J., YONA, S., GAVINS, F.N., PERRETTI, M., HANNON, R., CROXTALL, J.D., BUCKINGHAM, J.C. & FLOWER, R.J. (2002). The annexin-1 knockout mouse: what it tells us about the inflammatory response. J. Physiol Pharmacol. 53, 541-553.
48. SJOLIN, C., STENDAHL, O. & DAHLGREN, C. (1994). Calcium-induced translocation of annexins to subcellular organelles of human neutrophils. Biochem. J., 300 (Part 2), 325-330.
49. TRAVERSO, V., CHRISTIAN, H.C., MORRIS, J.F. & BUCKINGHAM, J.C. (1999). Lipocortin 1 (annexin 1): a candidate paracrine agent localized in pituitary folliculo-stellate cells. Endocrinology, 140, 4311-4319.
50. UNDERHILL, D.M., OZINSKY, A., HAJJAR, A.M., STEVENS, A., WILSON, C.B., BASSETTI, M. & ADEREM, A. (1999). The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature, 401, 811-815.
51. WARD, I., DRANSFIELD, I., CHILVERS, E.R., HASLETT, I. & ROSSI, A.G. (1999). Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol. Sci., 20, 503-509.
52. WU, C.C., CROXTALL, J.D., PERRETTI, M., BRYANT, C.E., THIEMERMANN, C., FLOWER, R.J. & VANE, J.R. (1995). Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc. Natl. Acad. Sci. U.S.A., 92, 3473-3477.
53. YAMAMOTO, K., ARAKAWA, T., UEDA, N. & YAMAMOTO, S. (1995). Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem., 270, 31315-31320.
54. ZIMMERMAN, J.W., LINDERMUTH, J., FISH, P.A., PALACE, G.P., STEVENSON, T.T. & DeMONG, D.E. (1998). A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J. Biol. Chem., 273, 22014-22020.